UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058054
Receipt number R000066355
Scientific Title The study of the changes in defecation information by ingestion of probiotic food
Date of disclosure of the study information 2025/06/12
Last modified on 2025/06/02 16:39:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study of the changes in defecation information by ingestion of probiotic food

Acronym

The study of the changes in defecation information by ingestion of probiotic food

Scientific Title

The study of the changes in defecation information by ingestion of probiotic food

Scientific Title:Acronym

The study of the changes in defecation information by ingestion of probiotic food

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the changes in defecation information by constant ingestion of probiotic food

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Defecation-related indicator

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingest of probiotic food during the 4-week intervention period

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Those whose workplace is the TOTO Research Institute on the date of consent
2.Those who have received sufficient explanation about the purpose and content of this study, have the ability to consent, fully volunteered with voluntary intention, agreed to participate

Key exclusion criteria

1.Those who regularly use medicines that affect the intestinal environment, such as Intestinal regulator, constipation medicine, laxative.
2.Those who cannot stop taking foods for specified health uses, foods with functional claims, health foods, or foods containing lactobacillus, bifidobacterium, oligosaccharides, etc. during the study period.
3.Those who have a disease of the liver, kidneys, heart, lungs, digestive system, blood, endocrine system, or metabolism, or those who have a serious medical history of such diseases.
4.Those who have a serious drug or food allergy or a history of serious allergies.
5.Those who have a milk allergy or lactose intolerance.
6.Those who are pregnant, intend to become pregnant during the study period, or are breastfeeding.
7.Those who have participated in other drug or food trials within the past month, or those who intend to participate in such trials during the study.
8.Those who are deemed unsuitable as subjects by the study physician based on the results of the subject background, etc.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Masayuki
Middle name
Last name Oba

Organization

TOTO LTD. Research Institute

Division name

Life Science R&D Dept

Zip code

253-8577

Address

2-8-1, Honson, Chigasaki-City, KANAGAWA Pref., JAPAN

TEL

0467-54-3380

Email

masayuki.oba@jp.toto.com


Public contact

Name of contact person

1st name Ayano
Middle name
Last name Hosokawa

Organization

TOTO LTD. Research Institute

Division name

Life Science R&D Dept

Zip code

253-8577

Address

2-8-1, Honson, Chigasaki-City, KANAGAWA Pref., JAPAN

TEL

0467-54-3387

Homepage URL


Email

ayano.hosokawa@jp.toto.com


Sponsor or person

Institute

TOTO LTD. Research Institute

Institute

Department

Personal name



Funding Source

Organization

TOTO LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Conference of Clinical Research

Address

1-13-23 Minami-ikebukuro, Toshima-Ku, Tokyo, Japan

Tel

03-6868-7011

Email

jccr-info@jccr.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 04 Month 28 Day

Date of IRB


Anticipated trial start date

2025 Year 06 Month 16 Day

Last follow-up date

2025 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 06 Month 02 Day

Last modified on

2025 Year 06 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066355